30.08.2010 • NewsColumbian ChemicalsIMCDCarbon Black

Columbian Chemicals Company Enters New Territories with IMCD

Columbian Chemicals have announced an extension of the partnership with IMCD as their specialty carbon black distribution partner into the coatings, inks, plastics and other non rubber applications.

The new agreement will include Russia, Latvia, Lithuania, Estonia, Belarus, Kazakhstan, Ukraine, Morocco, Tunisia and Algeria, in addition to the existing territories of Belgium, France, Luxembourg, Netherlands, Turkey, the UK and Ireland.

With immediate effect, IMCD will handle the Raven, Conductex, Statex and Neotex product ranges and support the ongoing direct sales activity of Columbian Chemicals in all of the above regions.

"This is a second partnership extension with Columbian this year", says Marcus Jordan, director group development at IMCD. "Not only are we able to provide the needed focus on specialty products to Columbian, but they will also be able to enter new geographic territories with us this time."

Columbian's products enable IMCD to further strengthen the package offered by the group's dedicated team of technical sales executives to its industrial customers.

Company

Logo:

IMCD Group B.V.

Wilhelminaplein 32
3072 Rotterdam
Netherlands

Company contact







Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.